1-3 of 3
Jose A. Queizan
Close
Sort by
Journal Articles

Validation of the NCCN-IPI for Diffuse Large B-Cell Lymphoma (DLBCL) in a Nation-Wide Spanish Series of 1885 Patients. the Geltamo-IPI Project

Carlos Montalbán, MDPhD, Antonio Díaz-López, PhD, Heidys Garrote Santana, MD, Julián Matias Freue, MD, Lourdes López, MD, Raquel De Oña, MD, Ana M Martín Moreno, PhD, Armando López-Guillermo, Ivan Dlouhi, Jordina Rovira, Mario Rodríguez, José Maria Sánchez Pina, Sara Alonso, MD, Alejandro Martín García, MDPhD, Silvana Novelli, MD, Juan-Manuel Sancho, Olga García, Antonio Salar, MD PhD, Antonio Gutierrez, MD PhD, Mariana Bastos, Maria Rodriguez-Salazar, MD PhD, Ruben Fernández, Juan F. Domínguez, Jose A. Queizán, Sonia González de Villambrosia, Raúl Córdoba, Victor Abraira, Jose Rodríguez, MD, Juan F. Garcia, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3955.
https://doi.org/10.1182/blood.V126.23.3955.3955
Published: 2015
Journal Articles

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Brief Report
Carlos M. Santamaría, María C. Chillón, Ramón García-Sanz, Cristina Pérez, María D. Caballero, Fernando Ramos, Alfonso García de Coca, José M. Alonso, Pilar Giraldo, Teresa Bernal, José A. Queizán, Juan N. Rodriguez, Pascual Fernández-Abellán, Abelardo Bárez, María J. Peñarrubia, Ana Balanzategui, María B. Vidriales, María E. Sarasquete, Miguel Alcoceba, Joaquín Díaz-Mediavilla, Jesús F. San Miguel, Marcos Gonzalez
Journal: Blood
Blood (2009) 114 (1): 148–152.
https://doi.org/10.1182/blood-2008-11-187724
Published: 2009
Journal Articles

Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta

Juan L. Garcia, Jaime Font de Mora, Jesus M. Hernandez, Jose A. Queizan, Norma C. Gutierrez, Jose M. Hernandez, Jesus F. San Miguel
Journal: Blood
Blood (2003) 102 (7): 2699–2700.
https://doi.org/10.1182/blood-2003-05-1579
Published: 2003